Literature DB >> 16222735

KL-6 mucin expression in carcinoma of the ampulla of Vater: association with cancer progression.

Wei Tang1, Yoshinori Inagaki, Norihiko Kokudo, Qian Guo, Yasuji Seyama, Munehiro Nakata, Hiroshi Imamura, Keiji Sano, Yasuhiko Sugawara, Masatoshi Makuuchi.   

Abstract

AIM: To assess histochemical expression of KL-6 and its clinicopathological significance in carcinoma of the ampulla of Vater.
METHODS: Ampullary carcinoma tissues were collected from 38 patients who underwent pancreatoduodenectomy or local resection. Tissues were subjected to immunohistochemical analysis using KL-6 antibody.
RESULTS: Positive staining of ampullary carcinoma cells was observed in 26 (68.4%) cases. Staining was not found in the surrounding non-cancer regions of the ampullary tissues. Remarkable KL-6 expression was observed in invasive carcinoma cells in pancreatic and duodenal tissues and in metastatic carcinoma cells in lymph nodes. Positive KL-6 expression was related to lymph node metastasis (P = 0.020), pancreatic invasion (P = 0.016), duodenal invasion (P = 0.034), and advanced stage of TNM clinical classification (P = 0.010). Survival analysis showed that positive expression of KL-6 was related to a poorer prognosis (P = 0.029).
CONCLUSION: The aberrant expression of KL-6 mucin is significantly related to unfavorable behaviors of carcinoma of the ampulla of Vater.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16222735      PMCID: PMC4320352          DOI: 10.3748/wjg.v11.i35.5450

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

Review 1.  Possible functions of tumor-associated carbohydrate antigens.

Authors:  S Hakomori
Journal:  Curr Opin Immunol       Date:  1991-10       Impact factor: 7.486

Review 2.  Mucin glycoproteins in neoplasia.

Authors:  Y S Kim; J Gum; I Brockhausen
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

Review 3.  Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.

Authors:  N Kohno
Journal:  J Med Invest       Date:  1999-08

4.  MUC1 expression in intramucosal colorectal neoplasms. Possible involvement in histogenesis and progression.

Authors:  T Tanimoto; S Tanaka; K Haruma; M Yoshihara; K Sumii; G Kajiyama; F Shimamoto; N Kohno
Journal:  Oncology       Date:  1999-04       Impact factor: 2.935

Review 5.  Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism.

Authors:  S Hakomori
Journal:  Cancer Res       Date:  1996-12-01       Impact factor: 12.701

6.  DF3 expression in human gallbladder carcinoma: significance for lymphatic invasion.

Authors:  H Kashiwagi; H Kijima; S Dowaki; Y Ohtani; K Tobita; M Tsukui; Y Tanaka; H Matsubayasi; T Tsuchida; H Yamazaki; M Nakamura; Y Ueyama; M Tanaka; T Tajima; H Makuuchi
Journal:  Int J Oncol       Date:  2000-03       Impact factor: 5.650

7.  Differentiation pathways in duodenal and ampullary carcinomas: a comparative study on mucin and trefoil peptide expression, including gastric and colon carcinomas.

Authors:  Yesim Gürbüz; Günter Klöppel
Journal:  Virchows Arch       Date:  2004-04-08       Impact factor: 4.064

8.  Prognostic factors after resection of ampullary carcinoma: multivariate survival analysis in comparison with ductal cancer of the pancreatic head.

Authors:  J Klempnauer; G J Ridder; R Pichlmayr
Journal:  Br J Surg       Date:  1995-12       Impact factor: 6.939

9.  MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.

Authors:  S Nakamori; D M Ota; K R Cleary; K Shirotani; T Irimura
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

10.  Immunoreactive MUC1 expression at the deepest invasive portion correlates with prognosis of colorectal cancer.

Authors:  Y Hiraga; S Tanaka; K Haruma; M Yoshihara; K Sumii; G Kajiyama; F Shimamoto; N Kohno
Journal:  Oncology       Date:  1998 Jul-Aug       Impact factor: 2.935

View more
  3 in total

Review 1.  An approach to duodenal biopsies.

Authors:  S Serra; P A Jani
Journal:  J Clin Pathol       Date:  2006-05-05       Impact factor: 3.411

2.  Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues.

Authors:  Qian Guo; Wei Tang; Yoshinori Inagaki; Yutaka Midorikawa; Norihiro Kokudo; Yasuhiko Sugawara; Munehiro Nakata; Toshiro Konishi; Hirokazu Nagawa; Masatoshi Makuuchi
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

3.  Diagnostic and prognostic serum marker of cholangiocarcinoma (Review).

Authors:  Xiaojun Zeng; Hualin Tao
Journal:  Oncol Lett       Date:  2014-11-10       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.